Alpha Spread
Search stocks here...
SAGE
BAI
SCE
PIRI
Sign Up Log in
Dashboard AI Assistant Stock Comparison Intrinsic Value Calculator DCF Value Calculator Stock Screener
Pricing Market News Investing Ideas
Settings
Alpha Spread
Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Alpha Spread
Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
SAGE Therapeutics Inc Logo

SAGE Therapeutics Inc
NASDAQ:SAGE

Watchlist Manager
SAGE Therapeutics Inc Logo
SAGE Therapeutics Inc
NASDAQ:SAGE
Watchlist
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Dividends
Investor Relations
Discount Rate
Price: 8.68 USD Market Closed
Market Cap: 544.9m USD
Have any thoughts about
SAGE Therapeutics Inc?
Write Note
Write Note Create Alert Ask AI
Add Note Why Create Notes?
Capture your thoughts
Note Buy Sell Hold Pass
US
Johnson & Johnson
NYSE:JNJ
Pharmaceuticals
US
Berkshire Hathaway Inc
NYSE:BRK.A
Financial Services
US
Bank of America Corp
NYSE:BAC
Banking
US
Mastercard Inc
NYSE:MA
Technology
US
UnitedHealth Group Inc
NYSE:UNH
Health Care
US
Exxon Mobil Corp
NYSE:XOM
Energy
US
Pfizer Inc
NYSE:PFE
Pharmaceuticals
US
Palantir Technologies Inc
NYSE:PLTR
Technology
US
Nike Inc
NYSE:NKE
Textiles, Apparel & Luxury Goods
US
Visa Inc
NYSE:V
Technology
CN
Alibaba Group Holding Ltd
NYSE:BABA
Retail
US
JPMorgan Chase & Co
NYSE:JPM
Banking
US
Coca-Cola Co
NYSE:KO
Beverages
US
Walmart Inc
NYSE:WMT
Retail
US
Verizon Communications Inc
NYSE:VZ
Telecommunication
US
Chevron Corp
NYSE:CVX
Energy


Add Price Alert
Price Target:
Last Price: 8.68 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch
Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?
Close
Back
Delete Note

Do you really want to delete this note?
This action cannot be undone.

Delete
Cancel
SAGE Alert
SAGE Therapeutics Inc
8.68
0.00 (0%)
52 Week Range
4.78
9.3
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

Johnson & Johnson
NYSE:JNJ
US
Berkshire Hathaway Inc
NYSE:BRK.A
US
Bank of America Corp
NYSE:BAC
US
Mastercard Inc
NYSE:MA
US
UnitedHealth Group Inc
NYSE:UNH
US
Exxon Mobil Corp
NYSE:XOM
US
Pfizer Inc
NYSE:PFE
US
Palantir Technologies Inc
NYSE:PLTR
US
Nike Inc
NYSE:NKE
US
Visa Inc
NYSE:V
US
Alibaba Group Holding Ltd
NYSE:BABA
CN
JPMorgan Chase & Co
NYSE:JPM
US
Coca-Cola Co
NYSE:KO
US
Walmart Inc
NYSE:WMT
US
Verizon Communications Inc
NYSE:VZ
US
Chevron Corp
NYSE:CVX
US
Delete Alert

This alert will be permanently deleted.

Delete
Cancel
Profitability SummaryPast GrowthMarginsReturn on CapitalFree Cash FlowSee Also
Section:
Profitability Summary
Past Growth
Margins
Return on Capital
Free Cash Flow
See Also

Profitability Summary

SAGE Therapeutics Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Due Diligence Checks:
Low Gross Margin
0%
Strong 3Y Average Gross Margin
83%
Negative Operating Margin
-430%
Negative 3Y Average Operating Margin
-3 516%
Operating Margin is Increasing
-8 103% > -430%
Negative Net Margin
-428%
View All Checks
Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Due Diligence Checks:
Low Gross Margin
0%
Strong 3Y Average Gross Margin
83%
Negative Operating Margin
-430%
Negative 3Y Average Operating Margin
-3 516%
Operating Margin is Increasing
-8 103% > -430%
Negative Net Margin
-428%
View All
View All
Low Gross Margin
0%
Strong 3Y Average Gross Margin
83%
Negative Operating Margin
-430%
Negative 3Y Average Operating Margin
-3 516%
Operating Margin is Increasing
-8 103% > -430%
Negative Net Margin
-428%
Negative 3Y Average Net Margin
-3 432%
Net Margin is Increasing
-7 975% > -428%
Negative ROE
-60%
Negative 3Y Average ROE
-50%
Declining ROE
-32% > -60%
Negative ROIC
-616%
Negative 3Y Average ROIC
-730%
ROIC is Increasing
-630% > -616%
Hide
Collapse
Sign Up to see
Profitability Score
Sign In
Sign Up

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less
0
Revenue
+0%
3Y
+1 054%
5Y
+682%
10Y
-
0
Operating Income
+0%
3Y
+40%
5Y
+50%
10Y
-374%
0
Net Income
+0%
3Y
+40%
5Y
+51%
10Y
-369%

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less
0
Operating Margin
0
Net Margin

Earnings Waterfall
SAGE Therapeutics Inc

Revenue
70.4m USD
Operating Expenses
-373.1m USD
Operating Income
-302.7m USD
Other Expenses
1.5m USD
Net Income
-301.2m USD

Margins Comparison
SAGE Therapeutics Inc Competitors

Country Company Market Cap Operating
Margin
Net
Margin
US
SAGE Therapeutics Inc
NASDAQ:SAGE
543.6m USD
-430%
-428%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
-21 040%
US
Abbvie Inc
NYSE:ABBV
385.2B USD
31%
6%
US
Amgen Inc
NASDAQ:AMGN
160.6B USD
31%
19%
US
Gilead Sciences Inc
NASDAQ:GILD
148.8B USD
39%
28%
US
E
Epizyme Inc
F:EPE
94.1B EUR
-370%
-392%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
109.1B USD
39%
32%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
68.6B USD
28%
32%
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
59.7B USD
-7%
-13%
AU
CSL Ltd
ASX:CSL
84.9B AUD
26%
19%
NL
argenx SE
XBRU:ARGX
43.2B EUR
22%
43%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less
0
ROE
0
ROA
ROCE
HIDDEN
Unlock
ROIC
HIDDEN
Unlock

Return on Capital Comparison
SAGE Therapeutics Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
SAGE Therapeutics Inc
NASDAQ:SAGE
543.6m USD
-60%
-54%
-60%
-616%
FR
Pharnext SCA
OTC:PNEXF
6T USD
115%
-391%
275%
3 093%
US
Abbvie Inc
NYSE:ABBV
385.2B USD
113%
3%
18%
23%
US
Amgen Inc
NASDAQ:AMGN
160.6B USD
99%
7%
16%
14%
US
Gilead Sciences Inc
NASDAQ:GILD
148.8B USD
41%
14%
25%
19%
US
E
Epizyme Inc
F:EPE
94.1B EUR
-877%
-67%
-73%
-182%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
109.1B USD
23%
16%
24%
26%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
68.6B USD
15%
12%
11%
12%
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
59.7B USD
-258%
-7%
-6%
-10%
AU
CSL Ltd
ASX:CSL
84.9B AUD
16%
8%
12%
10%
NL
argenx SE
XBRU:ARGX
43.2B EUR
30%
26%
15%
61%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less
0
Operating Cash Flow
+0%
3Y
+24%
5Y
+42%
10Y
-489%
0
Capital Expenditures
+0%
3Y
-
5Y
-
10Y
-
Free Cash Flow
HIDDEN
Unlock

See Also

Summary
SAGE intrinsic value, competitors valuation, and company profile.
DCF Valuation
SAGE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SAGE stock valuation using valuation multiples.
Wall Street Estimates
SAGE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SAGE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 293,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

The AI Assistant may be inaccurate

The AI Assistant may sometimes provide inaccurate information.

This is not financial advice

Make your own investment decisions or consult a licensed financial advisor.

Close
Alpha Spread
Recent chats
No chats
Dashboard Pricing
Sign Up
How can I help you with
SAGE Therapeutics Inc
Analyze what drives margins for SAGE Therapeutics Inc
Explain what drives SAGE Therapeutics Inc's profitability. Break down gross, operating, and net margins, what influences each, and which parts of the business have the most leverage. Start with a short summary.
SAGE
Evaluate SAGE Therapeutics Inc’s ability to generate free cash flow
Discuss how well SAGE Therapeutics Inc converts accounting profit into real cash. Compare net income vs free cash flow and highlight discrepancies (working capital, CapEx, timing). Include a small table showing FCF margin trend and summarize what this says about the quality of SAGE Therapeutics Inc’s earnings. Start with a short summary.
SAGE
Compare SAGE Therapeutics Inc’s profitability with peers
Compare SAGE Therapeutics Inc’s margins (gross, operating, net) and return metrics (ROE, ROIC) with its top competitors. Highlight where SAGE Therapeutics Inc stands out: efficiency, pricing power, scale, or cost structure. Include a compact table of key ratios vs peers. Start with a short verdict: “Is SAGE Therapeutics Inc more or less profitable than the industry, and why?”
SAGE
Analyze what drives margins for SAGE Therapeutics Inc
Explain what drives SAGE Therapeutics Inc's profitability. Break down gross, operating, and net margins, what influences each, and which parts of the business have the most leverage. Start with a short summary.
SAGE
Evaluate SAGE Therapeutics Inc’s ability to generate free cash flow
Discuss how well SAGE Therapeutics Inc converts accounting profit into real cash. Compare net income vs free cash flow and highlight discrepancies (working capital, CapEx, timing). Include a small table showing FCF margin trend and summarize what this says about the quality of SAGE Therapeutics Inc’s earnings. Start with a short summary.
SAGE
Compare SAGE Therapeutics Inc’s profitability with peers
Compare SAGE Therapeutics Inc’s margins (gross, operating, net) and return metrics (ROE, ROIC) with its top competitors. Highlight where SAGE Therapeutics Inc stands out: efficiency, pricing power, scale, or cost structure. Include a compact table of key ratios vs peers. Start with a short verdict: “Is SAGE Therapeutics Inc more or less profitable than the industry, and why?”
SAGE
Refresh
GPT-5 Mini
GPT-5 GPT-5 Mini

The AI Assistant may make mistakes. Consider checking important information. Learn more.

Alpha Spread
Become a more intelligent investor
Sign up with Google
OR
Sign up with email
Already have an account? Sign in
By using Alpha Spread you are agreeing to our
Terms of Service and Privacy Policy.
Sign In
Become a more intelligent investor
Sign in with Google
OR
Sign in with email
Not a member? Sign Up
By using Alpha Spread you are agreeing to our
Terms of Service and Privacy Policy.
Recently Viewed Most Popular Most Undervalued Wide Economic Moat High Profitability High Solvency
SAGE Therapeutics Inc
NASDAQ:SAGE
8.68 USD
BenevolentAI SA
AEX:BAI
0.081 EUR
Schweizer Electronic AG
F:SCE
3.2 EUR
-0.62%
Pires Investments PLC
LSE:PIRI
0.95 GBX

Companies most frequently analyzed and tracked by Alpha Spread users.

Johnson & Johnson
NYSE:JNJ
188.87 USD
-0.1%
Berkshire Hathaway Inc
NYSE:BRK.A
715 740 USD
-0.3%
Bank of America Corp
NYSE:BAC
53.45 USD
0.79%
Mastercard Inc
NYSE:MA
551.99 USD
-0.31%
UnitedHealth Group Inc
NYSE:UNH
341.56 USD
-0.93%
Exxon Mobil Corp
NYSE:XOM
114.36 USD
-0.29%
View Most Popular Stocks Full List

Every business has a fair value, its true price. Where market price tells you the price other people are willing to pay, fair value shows the value of a stock based on an analysis of the company’s actual financials (such as cash balance, revenue, operating margin, etc).

Franklin Covey Co
NYSE:FC
16.98 USD
0.18%
Mohawk Industries Inc
NYSE:MHK
113.64 USD
-1.69%
Ardmore Shipping Corp
NYSE:ASC
12.59 USD
1.04%
ASGN Inc
NYSE:ASGN
44.76 USD
2.12%
Skyworks Solutions Inc
NASDAQ:SWKS
77.72 USD
-1.82%
Weatherford International PLC
NASDAQ:WFRD
73.69 USD
1.57%
View Most Undervalued Stocks Full List

Economic Moat is a concept popularized by Warren Buffett to describe a company's durable competitive advantage. It represents the 'moat' that protects a company from competitors and helps it sustain profitability over the long term.

Johnson & Johnson
NYSE:JNJ
188.87 USD
-0.1%
Bank of America Corp
NYSE:BAC
53.45 USD
0.79%
Mastercard Inc
NYSE:MA
551.99 USD
-0.31%
Salesforce Inc
NYSE:CRM
260.41 USD
1.47%
Abbvie Inc
NYSE:ABBV
218.04 USD
-4.45%
Home Depot Inc
NYSE:HD
379.59 USD
0.01%
View Wide Economic Moat Stocks Full List

Companies demonstrating exceptional profitability and efficient operations.

Monolithic Power Systems Inc
NASDAQ:MPWR
1 005 USD
-7.59%
Applovin Corp
NASDAQ:APP
637.33 USD
2.69%
NVIDIA Corp
NASDAQ:NVDA
202.49 USD
-0.2%
Cal-Maine Foods Inc
NASDAQ:CALM
87.8 USD
1.07%
Pro Medicus Ltd
ASX:PME
261.6 AUD
0.28%
P
Plover Bay Technologies Ltd
HKEX:1523
6.39 HKD
-0.47%
View High Profitability Stocks Full List

Companies with the lowest probability of bankruptcy.

Salesforce Inc
NYSE:CRM
260.41 USD
1.47%
ServiceNow Inc
NYSE:NOW
919.28 USD
-1.65%
Spotify Technology SA
NYSE:SPOT
655.32 USD
-0.21%
Applied Materials Inc
NASDAQ:AMAT
233.1 USD
0.24%
NVIDIA Corp
NASDAQ:NVDA
202.49 USD
-0.2%
NetEase Inc
NASDAQ:NTES
140.1 USD
0.76%
View High Solvency Stocks Full List
AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Last conversations
Other Tools
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF
Stock Screener
Discover stocks

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett
Create Your Free Account
Already have an account? Sign in
Gain access to the world’s leading value investing platform
Gain access to the world’s leading value investing platform

By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.

Sign up with Google
OR
Create Free Account

By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.